| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 9.47e-06 | 7 | 131 | 3 | GO:0034988 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | HJV AKT3 VRK3 RPS6KA5 ALPK1 ACVR1C MELK MAP3K5 MTOR ROCK1 TOP1 | 1.75e-04 | 446 | 131 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.92e-04 | 127 | 131 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 3.37e-04 | 21 | 131 | 3 | GO:0034987 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.40e-04 | 262 | 131 | 8 | GO:0140097 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.34e-05 | 8 | 130 | 3 | GO:0001812 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ARHGEF19 CTTNBP2 ZEB2 NEDD9 RND3 XIRP2 ARHGEF10 MTOR TLN1 CTNNA3 ROCK1 AKAP11 ARHGAP25 TNFAIP1 ADPRHL1 EPDR1 MYO15A PREX1 | 1.69e-05 | 912 | 130 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 2.00e-05 | 9 | 130 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 2.72e-05 | 56 | 130 | 5 | GO:0002714 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 2.72e-05 | 56 | 130 | 5 | GO:0002891 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 2.84e-05 | 10 | 130 | 3 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 2.84e-05 | 10 | 130 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 2.84e-05 | 10 | 130 | 3 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 3.89e-05 | 11 | 130 | 3 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 3.89e-05 | 11 | 130 | 3 | GO:0002892 | |
| GeneOntologyBiologicalProcess | anterior neuropore closure | 3.94e-05 | 2 | 130 | 2 | GO:0021506 | |
| GeneOntologyBiologicalProcess | neuropore closure | 3.94e-05 | 2 | 130 | 2 | GO:0021995 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | ARHGEF19 CTTNBP2 ZEB2 NEDD9 RND3 XIRP2 ARHGEF10 MTOR TLN1 ROCK1 AKAP11 ARHGAP25 TNFAIP1 ADPRHL1 MYO15A PREX1 | 4.63e-05 | 803 | 130 | 16 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DOCK3 NRG1 ARHGEF19 MYO9A PREX2 ARHGEF10 KIF14 ARHGAP25 TNFAIP1 PREX1 | 5.06e-05 | 333 | 130 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 6.68e-05 | 13 | 130 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | ARHGEF19 VRK3 MYO9A ACVR1C PREX2 MAP3K5 NEDD9 ARHGEF10 MTOR ROCK1 ARHGAP25 PREX1 | 7.66e-05 | 499 | 130 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.05e-04 | 15 | 130 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 1.05e-04 | 15 | 130 | 3 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.05e-04 | 15 | 130 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | somatic diversification of immunoglobulins | 1.26e-04 | 77 | 130 | 5 | GO:0016445 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 1.43e-04 | 79 | 130 | 5 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 1.43e-04 | 79 | 130 | 5 | GO:0002889 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | 1.48e-04 | 241 | 130 | 8 | GO:0002377 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK3 NRG1 ARHGEF19 MYO9A PREX2 RND3 ARHGEF10 KIF14 ROCK1 ARHGAP25 TNFAIP1 PREX1 | 1.55e-04 | 538 | 130 | 12 | GO:0007264 |
| GeneOntologyBiologicalProcess | somatic hypermutation of immunoglobulin genes | 1.56e-04 | 17 | 130 | 3 | GO:0016446 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.56e-04 | 17 | 130 | 3 | GO:0002866 | |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors via somatic mutation | 1.86e-04 | 18 | 130 | 3 | GO:0002566 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 2.02e-04 | 85 | 130 | 5 | GO:0019731 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 2.20e-04 | 19 | 130 | 3 | GO:0002883 | |
| GeneOntologyBiologicalProcess | regulation of locomotor rhythm | 2.35e-04 | 4 | 130 | 2 | GO:1904059 | |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | 2.41e-04 | 403 | 130 | 10 | GO:0002440 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 2.58e-04 | 20 | 130 | 3 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 2.58e-04 | 20 | 130 | 3 | GO:1903140 | |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors | 2.78e-04 | 91 | 130 | 5 | GO:0002200 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ADAMTS19 KRT32 ZEB2 NEDD9 RND3 PXDN XIRP2 ARHGEF10 MTOR KIF14 ROCK1 ARHGAP25 TNFAIP1 ADPRHL1 MYO15A PREX1 | 3.46e-04 | 957 | 130 | 16 | GO:0097435 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 3.81e-04 | 150 | 130 | 6 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.81e-04 | 150 | 130 | 6 | GO:0002824 | |
| GeneOntologyBiologicalProcess | actin filament organization | ZEB2 NEDD9 RND3 XIRP2 ARHGEF10 MTOR ROCK1 ARHGAP25 TNFAIP1 MYO15A PREX1 | 3.84e-04 | 509 | 130 | 11 | GO:0007015 |
| GeneOntologyBiologicalProcess | myofibroblast contraction | 3.89e-04 | 5 | 130 | 2 | GO:1990764 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 3.95e-04 | 23 | 130 | 3 | GO:0002863 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | MARCHF10 RPS6KA5 MED8 RNF8 FBXO38 RNF220 TRIM69 USP38 MTOR SHPRH MINAR1 TNFAIP1 HERC6 GNL3 HERC5 TRIM51G PARP15 | 4.21e-04 | 1074 | 130 | 17 | GO:0043687 |
| GeneOntologyBiologicalProcess | positive regulation of B cell activation | 4.29e-04 | 100 | 130 | 5 | GO:0050871 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | ARHGEF19 ZEB2 NEDD9 RND3 XIRP2 ARHGEF10 MTOR CTNNA3 ROCK1 PREX1 | 4.65e-04 | 438 | 130 | 10 | GO:0032970 |
| GeneOntologyBiologicalProcess | hypersensitivity | 5.08e-04 | 25 | 130 | 3 | GO:0002524 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 5.19e-04 | 159 | 130 | 6 | GO:0002821 | |
| GeneOntologyBiologicalProcess | 'de novo' pyrimidine nucleobase biosynthetic process | 5.82e-04 | 6 | 130 | 2 | GO:0006207 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 6.41e-04 | 27 | 130 | 3 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RGPD2 NRG1 ARHGEF19 VRK3 MYO9A ACVR1C ZEB2 PREX2 MAP3K5 NEDD9 ARHGEF10 MTOR KIF14 ROCK1 ARHGAP25 PREX1 | 7.53e-04 | 1028 | 130 | 16 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 8.57e-04 | 175 | 130 | 6 | GO:0002705 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 8.77e-04 | 30 | 130 | 3 | GO:0002888 | |
| GeneOntologyCellularComponent | proteasome storage granule | 4.02e-05 | 2 | 133 | 2 | GO:0034515 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 8.71e-05 | 14 | 133 | 3 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.60e-04 | 17 | 133 | 3 | GO:0042571 | |
| GeneOntologyCellularComponent | proteasome regulatory particle | 3.55e-04 | 22 | 133 | 3 | GO:0005838 | |
| GeneOntologyCellularComponent | proteasome accessory complex | 5.23e-04 | 25 | 133 | 3 | GO:0022624 | |
| MousePheno | absent memory B cells | 1.83e-06 | 4 | 109 | 3 | MP:0008094 | |
| MousePheno | abnormal B cell differentiation | PMS2 CTTNBP2 RNF8 TNFRSF11B RIF1 MTOR IGHG2 IGHG3 IGHG4 ERCC6L2 POLQ REV1 | 2.37e-06 | 287 | 109 | 12 | MP:0002144 |
| MousePheno | abnormal class switch recombination | 3.12e-06 | 81 | 109 | 7 | MP:0004816 | |
| MousePheno | decreased memory B cell number | 3.74e-05 | 9 | 109 | 3 | MP:0008729 | |
| MousePheno | decreased IgG1 level | 6.29e-05 | 128 | 109 | 7 | MP:0008495 | |
| MousePheno | decreased IgG2c level | 7.27e-05 | 11 | 109 | 3 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 7.27e-05 | 11 | 109 | 3 | MP:0008093 | |
| MousePheno | increased susceptibility to xenobiotic induced morbidity/mortality | 8.02e-05 | 133 | 109 | 7 | MP:0009766 | |
| MousePheno | embryonic growth arrest | NRG1 GATAD2A HUS1 SALL4 SS18 ZEB2 MTOR TLN1 DDX11L8 GNL3 VCL | 8.03e-05 | 346 | 109 | 11 | MP:0001730 |
| MousePheno | abnormal plasma cell number | 9.41e-05 | 59 | 109 | 5 | MP:0008096 | |
| MousePheno | abnormal lymphopoiesis | GADD45B PMS2 CTTNBP2 RNF8 TNFRSF11B RIF1 MTOR IGHG2 IGHG3 IGHG4 ERCC6L2 POLQ REV1 | 1.12e-04 | 490 | 109 | 13 | MP:0002401 |
| MousePheno | abnormal memory B cell morphology | 1.58e-04 | 14 | 109 | 3 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 1.96e-04 | 15 | 109 | 3 | MP:0008099 | |
| MousePheno | abnormal B cell morphology | PMS2 CTTNBP2 RNF8 ITGAL TNFRSF11B NEDD9 RIF1 MTOR IGHG2 IGHG3 IGHG4 ERCC6L2 POLQ REV1 | 2.19e-04 | 597 | 109 | 14 | MP:0004939 |
| MousePheno | increased plasma cell number | 2.58e-04 | 40 | 109 | 4 | MP:0008097 | |
| MousePheno | abnormal IgG2b level | 2.64e-04 | 114 | 109 | 6 | MP:0020177 | |
| MousePheno | abnormal mesoderm development | 2.76e-04 | 74 | 109 | 5 | MP:0001680 | |
| MousePheno | enhanced humoral immune response | 2.90e-04 | 17 | 109 | 3 | MP:0020155 | |
| MousePheno | abnormal plasma cell morphology | 2.94e-04 | 75 | 109 | 5 | MP:0002439 | |
| MousePheno | increased susceptibility to type I hypersensitivity reaction | 3.42e-04 | 43 | 109 | 4 | MP:0005596 | |
| MousePheno | decreased IgG2 level | 3.48e-04 | 120 | 109 | 6 | MP:0013804 | |
| MousePheno | slow movement | 3.58e-04 | 4 | 109 | 2 | MP:0020211 | |
| MousePheno | abnormal xenobiotic induced morbidity/mortality | 3.79e-04 | 171 | 109 | 7 | MP:0009765 | |
| Domain | Vinculin/catenin | 7.48e-08 | 7 | 129 | 4 | IPR006077 | |
| Domain | VINCULIN_1 | 1.28e-06 | 4 | 129 | 3 | PS00663 | |
| Domain | Vinculin_CS | 1.28e-06 | 4 | 129 | 3 | IPR000633 | |
| Domain | Vinculin | 3.19e-06 | 5 | 129 | 3 | PF01044 | |
| Domain | ARM-type_fold | DOCK3 INTS7 PSMD1 PSMD2 WDFY4 RIF1 VAC14 MTOR VPS35 MROH7 HEATR5B UNC79 | 4.12e-06 | 339 | 129 | 12 | IPR016024 |
| Domain | - | 2.40e-05 | 222 | 129 | 9 | 1.25.10.10 | |
| Domain | PH_dom-like | RGPD2 AKT3 ARHGEF19 ANKS1B WDFY4 PREX2 ARHGEF10 TLN1 ROCK1 ARHGAP25 PLCL1 PREX1 | 4.01e-05 | 426 | 129 | 12 | IPR011993 |
| Domain | ARM-like | 1.09e-04 | 270 | 129 | 9 | IPR011989 | |
| Domain | PC_rep | 1.41e-04 | 3 | 129 | 2 | PF01851 | |
| Domain | Proteasome/cyclosome_rpt | 1.41e-04 | 3 | 129 | 2 | IPR002015 | |
| Domain | Alpha_catenin | 2.81e-04 | 4 | 129 | 2 | IPR001033 | |
| Domain | - | RGPD2 AKT3 ARHGEF19 ANKS1B PREX2 TLN1 ROCK1 ARHGAP25 PLCL1 PREX1 | 3.89e-04 | 391 | 129 | 10 | 2.30.29.30 |
| Domain | - | 6.97e-04 | 6 | 129 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 6.97e-04 | 6 | 129 | 2 | IPR016071 | |
| Pathway | REACTOME_PTEN_REGULATION | 4.49e-07 | 98 | 100 | 8 | MM15348 | |
| Pathway | REACTOME_PTEN_REGULATION | 6.04e-07 | 139 | 100 | 9 | M27646 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 7.27e-05 | 12 | 100 | 3 | M12851 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 7.46e-05 | 252 | 100 | 9 | MM15585 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 7.46e-05 | 313 | 100 | 10 | M27867 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 1.27e-04 | 69 | 100 | 5 | MM15540 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 1.27e-04 | 69 | 100 | 5 | M27815 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 1.97e-04 | 41 | 100 | 4 | M232 | |
| Pubmed | CD62L expression marks a functionally distinct subset of memory B cells. | 1.64e-08 | 8 | 138 | 4 | 38060451 | |
| Pubmed | The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response. | 2.94e-08 | 9 | 138 | 4 | 31767615 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 2.44e-07 | 4 | 138 | 3 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 2.44e-07 | 4 | 138 | 3 | 11812141 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 2.44e-07 | 4 | 138 | 3 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 2.44e-07 | 4 | 138 | 3 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 2.44e-07 | 4 | 138 | 3 | 19050247 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 2.44e-07 | 4 | 138 | 3 | 30287618 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 7892607 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 2.44e-07 | 4 | 138 | 3 | 25363774 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 2.44e-07 | 4 | 138 | 3 | 12414967 | |
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 2.44e-07 | 4 | 138 | 3 | 8438159 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 4098598 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 2.44e-07 | 4 | 138 | 3 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 2.44e-07 | 4 | 138 | 3 | 6803173 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6264445 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 2.44e-07 | 4 | 138 | 3 | 25867470 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 1542303 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 2.44e-07 | 4 | 138 | 3 | 9126488 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 8452816 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 4831970 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 7439686 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6278424 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 35133976 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 2.44e-07 | 4 | 138 | 3 | 32006024 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 12209645 | ||
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 2.44e-07 | 4 | 138 | 3 | 117549 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 116231 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 25451975 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 2.44e-07 | 4 | 138 | 3 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 2.44e-07 | 4 | 138 | 3 | 6801765 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6306571 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 2.44e-07 | 4 | 138 | 3 | 1713710 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 2.44e-07 | 4 | 138 | 3 | 9103199 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 2.44e-07 | 4 | 138 | 3 | 98524 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 38268239 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 2.44e-07 | 4 | 138 | 3 | 6799207 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6787604 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 2.44e-07 | 4 | 138 | 3 | 19703988 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 2.44e-07 | 4 | 138 | 3 | 6767246 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 12051834 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 8683112 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 2.44e-07 | 4 | 138 | 3 | 807855 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 4166666 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 26201558 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6249338 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 2.44e-07 | 4 | 138 | 3 | 19592272 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 10720538 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 24752300 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 15699144 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 2513486 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 36763580 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 2.44e-07 | 4 | 138 | 3 | 3921826 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 2.44e-07 | 4 | 138 | 3 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 2.44e-07 | 4 | 138 | 3 | 6766534 | |
| Pubmed | CENPF PSMD1 PSMD2 PSMD12 RIF1 MTOR TLN1 MCM3AP KIF14 CTNNA1 TOP1 GNL3 VCL HERC5 | 3.66e-07 | 653 | 138 | 14 | 22586326 | |
| Pubmed | RPS6KA5 MYO9A EXPH5 PSMD1 EVPL TTC1 SS18 MAP3K5 RIF1 KIAA1549L MCM3AP CTNNA1 | 6.01e-07 | 486 | 138 | 12 | 20936779 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 6.08e-07 | 5 | 138 | 3 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 6.08e-07 | 5 | 138 | 3 | 6770027 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 6.08e-07 | 5 | 138 | 3 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 6.08e-07 | 5 | 138 | 3 | 20031218 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 6.08e-07 | 5 | 138 | 3 | 30359469 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 9834201 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 103631 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 33163250 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 37310381 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 36853944 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 23423996 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 6.08e-07 | 5 | 138 | 3 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 6.08e-07 | 5 | 138 | 3 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 6.08e-07 | 5 | 138 | 3 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 6.08e-07 | 5 | 138 | 3 | 26620759 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 32640012 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 6.08e-07 | 5 | 138 | 3 | 34539636 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 3031474 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 33025844 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 6.08e-07 | 5 | 138 | 3 | 6798155 | |
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 6.08e-07 | 5 | 138 | 3 | 24548411 | |
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 6.08e-07 | 5 | 138 | 3 | 6781756 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 6.08e-07 | 5 | 138 | 3 | 9743367 | |
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 6.08e-07 | 5 | 138 | 3 | 16301663 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 9707605 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 27457619 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 30705065 | ||
| Interaction | ADAMTS16 interactions | 9.87e-06 | 7 | 134 | 3 | int:ADAMTS16 | |
| Interaction | IGHV4-31 interactions | 1.57e-05 | 8 | 134 | 3 | int:IGHV4-31 | |
| Interaction | H2BC21 interactions | GATAD2A VRK3 RPS6KA5 CENPF RNF8 MCM3 DRAP1 MELK TFAP2A PALB2 RIF1 KIAA1549L TLN1 SHPRH AKAP11 TOP1 | 1.59e-05 | 696 | 134 | 16 | int:H2BC21 |
| Cytoband | 2q23.3 | 2.49e-05 | 19 | 138 | 3 | 2q23.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.73e-05 | 15 | 93 | 3 | 529 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.71e-04 | 66 | 93 | 4 | 722 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 5.41e-04 | 7 | 93 | 2 | 917 | |
| GeneFamily | Proteasome | 1.40e-03 | 43 | 93 | 3 | 690 | |
| GeneFamily | Ring finger proteins | 2.96e-03 | 275 | 93 | 6 | 58 | |
| Coexpression | GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN | 8.31e-06 | 193 | 137 | 8 | M7586 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 1.08e-05 | 200 | 137 | 8 | M9777 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 1.63e-05 | 102 | 137 | 6 | M5601 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.79e-05 | 155 | 137 | 7 | M39246 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 2.67e-05 | 165 | 137 | 7 | M8121 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 2.97e-05 | 12 | 137 | 3 | M34000 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 5.31e-05 | 250 | 137 | 8 | M11318 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DOCK3 ZNF717 PMS2 RPS6KA5 CENPF MYO9A PSMD2 SALL4 RNF17 MELK PALB2 MAP3K5 RIF1 MTOR CCDC62 ERCC6L2 KIF14 CCDC25 AKAP11 REV1 | 1.93e-07 | 820 | 133 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DOCK3 ZNF717 RPS6KA5 CENPF INTS7 MCM3 PSMD2 SALL4 RNF17 MELK PALB2 ADGRG6 RIF1 VAC14 POLR3B MTOR KIF14 AKAP11 | 3.84e-06 | 822 | 133 | 18 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.19e-05 | 134 | 133 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DOCK3 CENPF MYO9A PSMD2 SALL4 RNF17 MELK PALB2 MAP3K5 RIF1 POLR3B MTOR KIF14 AKAP11 GNL3 REV1 | 4.82e-05 | 810 | 133 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.83e-05 | 333 | 133 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.44e-05 | 361 | 133 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | PMS2 RPS6KA5 LCORL MYO9A HEMGN MCM3 SALL4 RNF17 PALB2 RIF1 AGO3 SHPRH ROCK1 TOP1 ZNF541 | 1.07e-04 | 776 | 133 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.44e-08 | 171 | 138 | 8 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | Healthy_donor-B_intermediate|World / disease group, cell group and cell class (v2) | 1.57e-07 | 192 | 138 | 8 | f77007b284e11f8654ad599eef929df7c6c4ebf0 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 1.47e-06 | 179 | 138 | 7 | 7d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 180 | 138 | 7 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 180 | 138 | 7 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 180 | 138 | 7 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 186 | 138 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 187 | 138 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-06 | 188 | 138 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-06 | 188 | 138 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-06 | 188 | 138 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-06 | 189 | 138 | 7 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-06 | 192 | 138 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-06 | 194 | 138 | 7 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 2.59e-06 | 195 | 138 | 7 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7-Slc17a6.Nptxr-Rorb_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.60e-06 | 125 | 138 | 6 | be820e4db3da737101f34ea9d2848a3ceb53f417 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 2.68e-06 | 196 | 138 | 7 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.86e-06 | 198 | 138 | 7 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 2.96e-06 | 199 | 138 | 7 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.42e-06 | 142 | 138 | 6 | d08e1880425d285c4433014fe0242ac7ff7734af | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 1.07e-05 | 160 | 138 | 6 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.32e-05 | 166 | 138 | 6 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.37e-05 | 167 | 138 | 6 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 1.42e-05 | 168 | 138 | 6 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 170 | 138 | 6 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-05 | 171 | 138 | 6 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.57e-05 | 171 | 138 | 6 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-3|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.74e-05 | 103 | 138 | 5 | 91fe062dcadd12fdb04fa4593a794c57f3f0411d | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-05 | 175 | 138 | 6 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.90e-05 | 177 | 138 | 6 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 178 | 138 | 6 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 1.97e-05 | 178 | 138 | 6 | 67aa17b17da3121c199af45e747c23e2626a9bb2 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 179 | 138 | 6 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 179 | 138 | 6 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 179 | 138 | 6 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 179 | 138 | 6 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 181 | 138 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-05 | 183 | 138 | 6 | 3ebe334ad570e3525341badb558f369c61daf3d3 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.30e-05 | 183 | 138 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 2.37e-05 | 184 | 138 | 6 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-05 | 184 | 138 | 6 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-05 | 184 | 138 | 6 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.37e-05 | 184 | 138 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 184 | 138 | 6 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-05 | 185 | 138 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.44e-05 | 185 | 138 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-05 | 186 | 138 | 6 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 2.52e-05 | 186 | 138 | 6 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.59e-05 | 187 | 138 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 188 | 138 | 6 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 188 | 138 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 188 | 138 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 188 | 138 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.72e-05 | 113 | 138 | 5 | fed408864201218295bac0cc6647953fda8d688e | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.72e-05 | 113 | 138 | 5 | c0b8d7a2e3722029e850051bdff77f31f34a8cca | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.72e-05 | 113 | 138 | 5 | 7e24c0f6a80e10a2a41325d48a87628bd330a1e2 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.72e-05 | 113 | 138 | 5 | 165de4316059222f33d1e51aeff4554037c0b937 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.75e-05 | 189 | 138 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.75e-05 | 189 | 138 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.75e-05 | 189 | 138 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.75e-05 | 189 | 138 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-05 | 189 | 138 | 6 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 189 | 138 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-05 | 189 | 138 | 6 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-05 | 189 | 138 | 6 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.84e-05 | 190 | 138 | 6 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-05 | 190 | 138 | 6 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 2.92e-05 | 191 | 138 | 6 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.92e-05 | 191 | 138 | 6 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.92e-05 | 191 | 138 | 6 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-05 | 191 | 138 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-05 | 191 | 138 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-05 | 191 | 138 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-05 | 191 | 138 | 6 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-05 | 191 | 138 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.92e-05 | 191 | 138 | 6 | b23fdcd3090df9f58310b4dc8f7dc0c6d6b33226 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.01e-05 | 192 | 138 | 6 | f9f64ad7bab1433e9a45adb7db7f43ce3f591b47 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.01e-05 | 192 | 138 | 6 | 4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.01e-05 | 192 | 138 | 6 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | Healthy/Control-B_intermediate|World / Disease group and Cell class | 3.01e-05 | 192 | 138 | 6 | 2266aa695955f5d885708e6bc0d5a8827c306223 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 193 | 138 | 6 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 193 | 138 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 193 | 138 | 6 | 8f1d6024ef092923321e6efd441b8d476db70aed | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 3.10e-05 | 193 | 138 | 6 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 3.19e-05 | 194 | 138 | 6 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 | |
| ToppCell | Healthy/Control-B_intermediate|Healthy/Control / Disease group and Cell class | 3.19e-05 | 194 | 138 | 6 | 8a4260eeccb4924c392798b1ffa23cdd3a4062e9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | 3.19e-05 | 194 | 138 | 6 | b57ae94a092b58623a244a258b4659a3864542c7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 195 | 138 | 6 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 195 | 138 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 195 | 138 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 195 | 138 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 195 | 138 | 6 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.38e-05 | 196 | 138 | 6 | f37ffb916480281e5905733ac304102dd2e0c05f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.38e-05 | 196 | 138 | 6 | 4b9eb163b9dbbf5eebb160f6554f6f28cb234d31 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-05 | 197 | 138 | 6 | 2662138671262b30508c5759038bcdcfe6551696 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.47e-05 | 197 | 138 | 6 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.47e-05 | 197 | 138 | 6 | 40c8ff067e8242e2ca083ea04cd6026168191a97 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 3.47e-05 | 197 | 138 | 6 | 4711ecb157e907758a5021248ae8b043d17672c6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.47e-05 | 197 | 138 | 6 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| Disease | immunoglobulin G measurement | 1.99e-05 | 2 | 132 | 2 | EFO_0020465 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.11e-04 | 26 | 132 | 3 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.37e-04 | 27 | 132 | 3 | C1112155 | |
| Disease | susceptibility to chronic sinus infection measurement | 2.50e-04 | 68 | 132 | 4 | EFO_0008419 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.94e-04 | 29 | 132 | 3 | C1333990 | |
| Disease | Hemimegalencephaly | 2.94e-04 | 6 | 132 | 2 | C0431391 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 3.59e-04 | 31 | 132 | 3 | C1335167 | |
| Disease | bone density | 3.71e-04 | 388 | 132 | 8 | EFO_0003923 | |
| Disease | Liver carcinoma | 4.77e-04 | 507 | 132 | 9 | C2239176 | |
| Disease | lung volume | 5.46e-04 | 8 | 132 | 2 | EFO_0600046 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 NRG1 CENPF TFAP2A ZEB2 PALB2 RIF1 DAZAP1 MTOR MROH7 UMPS TOP1 ZNF541 | 1.08e-03 | 1074 | 132 | 13 | C0006142 |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 1.27e-03 | 12 | 132 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Alzheimer disease, dementia | 1.27e-03 | 12 | 132 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | alcohol consumption measurement | MPP3 CTTNBP2 RPS6KA5 LCORL ANKS1B PSMD2 ALPK1 MTOR EIF2B1 CCDC25 AKAP11 ZFHX3 CTNNA1 MYO15A | 1.37e-03 | 1242 | 132 | 14 | EFO_0007878 |
| Disease | cognitive inhibition measurement | 1.47e-03 | 50 | 132 | 3 | EFO_0007969 | |
| Disease | interleukin-6 measurement | 1.64e-03 | 112 | 132 | 4 | EFO_0004810 | |
| Disease | episodic memory | 1.65e-03 | 52 | 132 | 3 | EFO_0004333 | |
| Disease | Malformations of Cortical Development | 1.74e-03 | 14 | 132 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.74e-03 | 14 | 132 | 2 | C0431380 | |
| Disease | birth weight, parental genotype effect measurement | 1.76e-03 | 192 | 132 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | Polydactyly | 1.92e-03 | 117 | 132 | 4 | C0152427 | |
| Disease | schizophrenia (biomarker_via_orthology) | 2.01e-03 | 15 | 132 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | hepatoblastoma (is_marker_for) | 2.01e-03 | 15 | 132 | 2 | DOID:687 (is_marker_for) | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.24e-03 | 122 | 132 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | Post-Traumatic Osteoporosis | 2.61e-03 | 61 | 132 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 2.61e-03 | 61 | 132 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 2.61e-03 | 61 | 132 | 3 | C0001787 | |
| Disease | reticulocyte measurement | GATAD2A LCORL HEMGN PSMD2 ACVR1C ZEB2 MAP3K5 ABCB4 RND3 RORB ARHGAP25 PREX1 | 2.77e-03 | 1053 | 132 | 12 | EFO_0010700 |
| Disease | Osteoporosis | 2.86e-03 | 63 | 132 | 3 | C0029456 | |
| Disease | serum hepcidin measurement | 2.90e-03 | 18 | 132 | 2 | EFO_0004504 | |
| Disease | Schizophrenia | 2.90e-03 | 18 | 132 | 2 | cv:C0036341 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 3.23e-03 | 19 | 132 | 2 | EFO_0003100, GO_1902519 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.23e-03 | 19 | 132 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.23e-03 | 19 | 132 | 2 | C2936783 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.25e-03 | 670 | 132 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | periodontitis | 3.35e-03 | 223 | 132 | 5 | EFO_0000649 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.55e-03 | 68 | 132 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | thyroid peroxidase antibody measurement | 4.17e-03 | 72 | 132 | 3 | EFO_0005666 | |
| Disease | nucleotide measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0010513 | |
| Disease | photoreceptor cell layer thickness measurement | 4.47e-03 | 148 | 132 | 4 | EFO_0803370 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NIDVKKMTVTDQVNC | 171 | P05090 | |
| GVMFQIDQATKQCSK | 101 | Q9UM22 | |
| IDQATKQCSKMTLTQ | 106 | Q9UM22 | |
| VMVAKQQEFKIECAA | 886 | O15013 | |
| LIFANKQDVKECMTV | 121 | Q9Y689 | |
| TAKMEQTKNKFCVLQ | 971 | Q9BXX2 | |
| VMNSSNQLCEQLKTI | 776 | Q14511 | |
| NQLCEQLKTIVMATK | 781 | Q14511 | |
| KKVKALESNQMECQT | 91 | Q6P9F0 | |
| LESNQMECQTALQKT | 96 | Q6P9F0 | |
| LVNMCQSALQDKKDS | 116 | Q13829 | |
| TMNAKILSNLSCNVK | 316 | Q86SQ4 | |
| TMQSISNEQKACKVL | 311 | P28223 | |
| LVAKACITNKVNMVT | 561 | Q9UDR5 | |
| IKLNNTMNACAVIAA | 191 | Q8IZP9 | |
| MLTNGKEQVIKSCVS | 51 | Q8NER5 | |
| QVTRKNMLLATKQIC | 331 | P05549 | |
| NMLQIDVKDICKSFT | 41 | P10632 | |
| QEAAKTTKVQCNSRM | 1381 | Q9UKA4 | |
| QQTLFSMKAIQKQCE | 961 | Q8IYA2 | |
| SMKAIQKQCETLQKN | 966 | Q8IYA2 | |
| LGMATQCVQVKNVIK | 541 | Q9H9G7 | |
| VVDCVIMKDKTTNQS | 36 | Q96EP5 | |
| MKSCAQSQAVTKIQG | 276 | Q5H9R4 | |
| TQNSQQCMLKKIFEG | 211 | P26436 | |
| LNNFSVAKCQLMKTE | 51 | Q9Y243 | |
| MNNQKVVAVLLQECK | 1 | Q96QP1 | |
| LTMQEGNSKVSQKCV | 1136 | Q68CQ1 | |
| KKACQVTQSRNAKTM | 51 | Q14919 | |
| ATRKLTIIFKNMQEC | 216 | Q6ZVN8 | |
| SCTKIMSKNISIVDN | 941 | Q8TE59 | |
| QATLKIALNCMVKLA | 406 | Q9NVH2 | |
| LCVVNFNILVENKMK | 101 | Q9Y5G8 | |
| CTENVPMKVQNQEKA | 221 | Q02297 | |
| LKCQTQSDFGKVTMQ | 596 | Q14680 | |
| KELVQECNASVQSMK | 551 | Q8IW93 | |
| NCQKSTEQMKKVPTI | 1091 | Q7Z6G8 | |
| CMTTNQKKALKVEHT | 441 | Q86YP4 | |
| QCTKNEVTKEMKTNA | 1446 | Q15058 | |
| QIMANIIKKCLTTVE | 181 | Q460N3 | |
| KMLDAKQNQCIIISG | 1301 | Q9UKN7 | |
| KILCTKAENARMVVN | 156 | Q14532 | |
| IVCKSIQMNQAENSL | 191 | Q8N3X6 | |
| SSKGDQMISVNVCIK | 1416 | O60318 | |
| IINKIGTNQMAVCAK | 206 | Q14232 | |
| DNKCSIKTAVAKNML | 1836 | Q92817 | |
| KIMTLNDIKIIQVSC | 121 | Q8IVU3 | |
| QIFMENVGAVKQLCK | 536 | Q96LU7 | |
| KKFCNETDVSQMLKQ | 66 | Q8NEV8 | |
| SCKFAQTMEQRLQKA | 956 | Q6ZVL6 | |
| MEANTQKEITALKLC | 461 | O75582 | |
| QLKQAVAKMVQQCCT | 96 | O00232 | |
| QLNSLHQETIMKCVK | 81 | Q9NX08 | |
| QQCVIMAENKKSSII | 71 | Q15195 | |
| KANSIQGCKMNNVNV | 76 | Q86WR0 | |
| SVLQDNSSKICQDMK | 181 | Q9BXL5 | |
| LKNSQMCQKSLDVET | 671 | P21439 | |
| KLVQMFKTAVICQLD | 541 | Q9UII4 | |
| MSNCQRKVAVEAVIQ | 416 | Q86YC2 | |
| IACNVKQMSKDAQPS | 261 | P25205 | |
| VLKSKNLVGVTMTNC | 921 | Q6PIJ6 | |
| SNTLNIALDNMCKKT | 356 | Q9UI47 | |
| ICQAIGKQMKAVEAV | 381 | Q9P2D3 | |
| ETENKKIGCTVNLMN | 1211 | Q8IZD9 | |
| AAKNLMNAVVQTVKA | 821 | P35221 | |
| CSLQTTMNKLNELEK | 1291 | P49454 | |
| MSEQNICNQKDKSTL | 1 | Q9P1J3 | |
| TEGMKNKTISQLNCN | 1481 | Q8WZ74 | |
| LVACDNAAQKMQTVT | 6 | O75293 | |
| ALRNKMNSQVCEKVT | 196 | P17213 | |
| TGINQFMTETVKNCK | 2421 | O75417 | |
| KALVENLCMKAVNQS | 831 | A8MPP1 | |
| NVCKENSTVGMKIQE | 21 | Q8NDY3 | |
| VVQQEGLMCNTKLKR | 181 | Q8NA82 | |
| GKSSIINSLKQEQMC | 266 | Q9BVP2 | |
| QSKMESAQDVQTICK | 716 | Q9ULL0 | |
| DSVCKLQQKVQNSKM | 386 | Q8IYX8 | |
| EMTKNQVSLTCLVKG | 236 | P01859 | |
| EEMTKNQVSLTCLVK | 286 | P01860 | |
| EEMTKNQVSLTCLVK | 236 | P01861 | |
| PMKCSNEKVVNQEQS | 1101 | Q5T890 | |
| DLSQTQCQKKETEQM | 1006 | A2RUR9 | |
| QQTLFSMKAIQKQCE | 1151 | A2RUR9 | |
| SMKAIQKQCETLQKN | 1156 | A2RUR9 | |
| LKTKVLVLCLQQMNS | 446 | O60645 | |
| QMLKKKQTCTVADAT | 311 | Q8N7B9 | |
| CQKKFTNAVMLQQHI | 631 | Q9UJQ4 | |
| DQAKVLIKLTTAMCN | 481 | Q8IWE2 | |
| SSKSIMDPNQNVKCK | 11 | P61587 | |
| QSLNKMCSNLLEKIS | 141 | Q96G25 | |
| LEAIQAVMAKNKVCL | 466 | Q13368 | |
| CTVNNQQSKKIMVAA | 71 | Q9UPX6 | |
| KRQKAMQVDATVFTC | 471 | P42345 | |
| SLQSLKEIICQKNTM | 191 | Q99683 | |
| SSALNLMQICKGKNV | 171 | P78346 | |
| LMQICKGKNVIISSA | 176 | P78346 | |
| SIKEVANVCNQSLMK | 316 | Q08AM6 | |
| CINKMVNNLSSEVKE | 456 | O76064 | |
| ACSKLQKSALQMPQV | 1471 | B5MCY1 | |
| LNSKEVAQAKKAMSC | 211 | Q9Y2B2 | |
| QNSLRKMICQEVKAI | 806 | P0DJD1 | |
| IFTSCKDVVVQKQMA | 281 | Q13200 | |
| EKLSCMANSVIKNLQ | 2446 | Q5UIP0 | |
| KCQNKEQFVEVMASA | 471 | Q9NYY8 | |
| VNPTKALCNIVNNKM | 246 | O60921 | |
| KTVCSNINETKRQME | 231 | Q8TCU6 | |
| MILKNTKDAVRNSVC | 351 | Q99460 | |
| FLLTTQMEELNKCQK | 1191 | Q149N8 | |
| SKQEAMQKTCKNSDI | 466 | Q5VTB9 | |
| SNKMKEGVNITICFQ | 641 | P20701 | |
| ELIKMTNEIQSNLKC | 1206 | Q9BXT8 | |
| QCLLAKDMLVSIQAK | 246 | Q86WT6 | |
| IMQSKSACEIKQSHQ | 2491 | A4UGR9 | |
| DTVQEKIVQCQKAGM | 986 | Q15111 | |
| QEQSNIVSADCQIMK | 1791 | Q86UP3 | |
| LEMIGNQVQSVKISC | 386 | O00300 | |
| ANAVRMEIKDQTKCA | 591 | Q9UBZ9 | |
| IQDQASAMQLSQCAK | 1011 | Q9Y490 | |
| QAVKVQSFQMKRCLD | 21 | Q96QK1 | |
| LIQCIMDSQNKGKTS | 31 | Q15532 | |
| NCAVNKMSVDNLATV | 301 | P42331 | |
| QCMAKNVAGEVKTQE | 316 | Q92626 | |
| MCENQLKTKADATAQ | 1 | Q92753 | |
| VENACTKLVQAAQML | 81 | P18206 | |
| SLVKSEKNRQVMCEA | 866 | Q6ZS81 | |
| LMQKKETNLCLSADV | 246 | P11172 | |
| LQAMKAVCSNINEAK | 201 | Q70Z35 | |
| ECQKAQIFTQMQALK | 271 | Q9NW08 | |
| TNIMDCLQNVFSKKL | 231 | P0CK96 | |
| KKLHSCQMSIQLLQT | 31 | O75764 | |
| TNCLPNTEDIMKQKQ | 391 | Q8IV63 | |
| NCASLQNAEKTMQIT | 741 | Q8NB14 | |
| CQKLVNTQDMSASQV | 591 | P54278 | |
| CSMLDVDLKQSQQKL | 741 | Q13464 | |
| MNVANVEKPCQKSVL | 731 | Q9BY31 | |
| TNICLKNMASIARKA | 66 | A0A3B3IT33 | |
| VTQMGNDKSIKCEQN | 31 | A0A576 | |
| IVDNTVSRQKMDCKA | 466 | O60315 | |
| KEMAINDCSKAIQLN | 171 | Q99614 | |
| MTNEEKNIITNLSKC | 286 | P11387 | |
| KNIITNLSKCDFTQM | 291 | P11387 | |
| MNKSQEQVSFKDVCV | 1 | Q8NDW4 | |
| LIHKMIQTKTVAQCV | 1186 | Q9H0D2 | |
| TQMTNLQLKVLKSCF | 2951 | Q15911 | |
| LQCTQFKMAQVEIQS | 2611 | Q9P2D8 | |
| MLQRKKNQCIVISGE | 226 | B2RTY4 |